Infectious Diseases Division, San Martino Hospital and University of Genoa School of Medicine, Genoa, Italy.
Clin Microbiol Infect. 2012 Sep;18(9):862-9. doi: 10.1111/j.1469-0691.2011.03679.x. Epub 2011 Oct 14.
Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥ 48 h after hospital admission (HCA ≥ 48 h), HCA SAB with onset <48 h of hospital admission (HCA <48 h), and CA SAB were compared with controls. Second, a cohort study including all patients with SAB was performed to identify factors associated with in-hospital mortality. SAB was diagnosed in 165 patients over the study period (January 2007 to December 2007). Five variables were independently associated with HCA ≥ 48 h SAB: presence of central venous catheter, solid tumour, chronic renal failure, previous hospitalization and previous antibiotic therapy. Significant risk factors for HCA <48 h SAB were: Charlson Comorbidity Index ≥ 3, previous hospitalization, living in long-term care facilities and corticosteroid therapy. Factors independently associated with CA SAB were: diabetes mellitus, HIV infection and chronic live disease. Patients with HCA <48 h SAB were significantly more likely to receive initial inadequate antimicrobial treatment than patients with CA or HCA ≥ 48 h SAB (44.8% versus 33.3% and 31.5%, respectively). Logistic-regression analysis identified three variables as independent predictors of mortality: presentation with septic shock, infection with methicillin-resistant S. aureus, and initial inadequate antimicrobial treatment. More than half of patients with SAB have MRSA strains and presentation with septic shock, and inappropriate empirical therapy was associated with increased mortality.
金黄色葡萄球菌菌血症(SAB)是医院和社区环境中导致死亡率和发病率的主要原因。本研究旨在探讨与医疗保健相关(HCA)和社区获得性(CA)SAB 相关的流行病学特征和易患风险因素,并评估初始抗菌治疗对治疗结果的死亡率和疗效的差异。我们进行了两部分分析。首先,我们进行了一项三病例对照研究,将入院后≥48 小时发病的 HCA SAB 组(HCA≥48 小时)、入院后<48 小时发病的 HCA SAB 组(HCA<48 小时)和 CA SAB 组与对照组进行比较。其次,对所有 SAB 患者进行了队列研究,以确定与院内死亡率相关的因素。在研究期间(2007 年 1 月至 2007 年 12 月)诊断出 165 例 SAB 患者。有五个变量与 HCA≥48 小时 SAB 独立相关:中心静脉导管、实体瘤、慢性肾功能衰竭、既往住院和既往抗生素治疗。HCA<48 小时 SAB 的显著危险因素是:Charlson 合并症指数≥3、既往住院、居住在长期护理机构和皮质激素治疗。与 CA SAB 独立相关的因素是:糖尿病、HIV 感染和慢性肝脏疾病。与 CA 或 HCA≥48 小时 SAB 相比,HCA<48 小时 SAB 患者初始接受不适当抗菌治疗的可能性明显更高(分别为 44.8%、33.3%和 31.5%)。Logistic 回归分析确定了三个变量是死亡率的独立预测因素:表现为感染性休克、耐甲氧西林金黄色葡萄球菌感染和初始不适当的抗菌治疗。超过一半的 SAB 患者携带 MRSA 菌株并出现感染性休克,经验性治疗不当与死亡率增加有关。